Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-19
1998-11-03
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514382, 5142242, 514253, 514252, 514404, 514405, 514212, 514909, A61K 3141
Patent
active
058309098
ABSTRACT:
The invention is a method of using Angiotensin (AII) Antagonists as inhibitors of the growth of adipose tissue, reducing adipocyte growth and body weight gain.
REFERENCES:
patent: 5175164 (1992-12-01), Bagley et al.
patent: 5260325 (1993-11-01), Markwalder et al.
patent: 5266583 (1993-11-01), Ohtawa
patent: 5274104 (1993-12-01), Arnaud et al.
patent: 5376666 (1994-12-01), Duncia
patent: 5380739 (1995-01-01), Clark et al.
D. G. Beevers et al., Br. J. Clin. Pharmac. 18:51-56 (1984).
C. Richer et al., Eur. J. Pharmac. 79:23-29 (1982).
Crandall et al., Metabolism 42:511-515 (1993).
American Cyanamid Company
Reamer James H.
Seifert Arthur G.
LandOfFree
Angiotensin (AII) antagonists as inhibitors of the growth of adi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin (AII) antagonists as inhibitors of the growth of adi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin (AII) antagonists as inhibitors of the growth of adi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689491